Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/CHEBI_9316
http://purl.obolibrary.org/obo/CHEBI_9316
|
|---|---|
| Preferred Name | sufentanil |
| Synonyms |
N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide
sufentanil
Sufentanyl
C22H30N2O2S
N-{4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]piperidin-4-yl}-N-phenylpropanamide
N-[4-(methoxymethyl)-1-[2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropanamide
sufentanilum
N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | sufentanil
|
|---|---|
| label | sufentanil
|
| DBSynonym |
sufentanilum [inn-latin]
sufentanyl
sufentanil citrate
|
| ATCCode | N01AH03
|
| Definition | The carboxamide resulting from the formal condensation of the aryl amino group of 4-(methoxymethyl)-N-phenyl-1-[2-(2-thienyl)ethyl]piperidin-4-amine with propanoic acid.
|
| has effect |
See more
See less
|
| has pharmacological target | |
| activates | |
| type | |
| has role | |
| InChIKey | InChIKey=GGCSSNBKKAUURC-UHFFFAOYSA-N
|
| is metabolised by | |
| AHFScode | 28:08.08
|
| Synonym |
N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide
sufentanil
Sufentanyl
C22H30N2O2S
N-{4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]piperidin-4-yl}-N-phenylpropanamide
N-[4-(methoxymethyl)-1-[2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropanamide
sufentanilum
N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide
See more
See less
|
| xref |
CiteXplore:10945855
ChEMBL:127638
Reaxys:499558
KEGG COMPOUND:C08022
Drugs.com:http://www.drugs.com/cdi/sufentanil.html
CiteXplore:11504823
Drugs Product Database (DPD):2244147
Patent:US3998834
Wikipedia:Sufentanil
Wikipedia:http://en.wikipedia.org/wiki/Sufentanil
ChEBI:9316
CiteXplore:16621415
BindingDB:50012490
PubChem Compound:41693
Guide To Pharmacology:3534
CiteXplore:9580589
CiteXplore:10628901
CiteXplore:11137863
DrugBank:DB00708
PubChem Substance:46504737
CiteXplore:15475572
CiteXplore:17118343
CiteXplore:15828831
National Drug Code Directory:11098-050-01
Patent:DE2610228
ChemSpider:38043
KEGG DRUG:D05938
CASRN:56030-54-7
IUPHAR:3534
PharmGKB:PA451527
See more
See less
|
| CASRN | 56030-54-7
|
| prefixIRI | obo2:CHEBI_9316
|
| related with | |
| SMILES |
CCC(=O)N(c1ccccc1)C1(CCN(CCc2cccs2)CC1)COC
CCC(=O)N(C1=CC=CC=C1)C1(COC)CCN(CCC2=CC=CS2)CC1
|
| may interact with | |
| DBname | sufentanil
|
| InChI | InChI=1S/C22H30N2O2S/c1-3-21(25)24(19-8-5-4-6-9-19)22(18-26-2)12-15-23(16-13-22)14-11-20-10-7-17-27-20/h4-10,17H,3,11-16,18H2,1-2H3
|
| DBBrand |
sufenta
chronogesic
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |